drugset / Trial / NCT00774332
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
NaSingle-groupOpen-labelTreatment
Summary
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Timeline
- Start
- 2006-06
- Primary completion
- 2006-06
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2-MERCAPTOETHANESULFONIC ACID | Small molecule | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | Leucovorin | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Vincristine | Small molecule | — | — |